ישראל - עברית - Ministry of Health

rafa laboratories ltd - tafluprost - תמיסה לעין - tafluprost 15 mcg/ml - tafluprost - tafluprost - reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.as monotherapy in patients • who would benefit from preservative free eye drops • insufficiently responsive to first line therapy • intolerant or contra-indicated to first line therapyas adjunctive therapy to beta-blockers.

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - tafluprost 15 mcg/ml - ophthalmic solution - tafluprost - reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.as monotherapy in patients • who would benefit from preservative free eye drops • insufficiently responsive to first line therapy • intolerant or contra-indicated to first line therapyas adjunctive therapy to beta-blockers.

ישראל - עברית - Ministry of Health

novartis israel ltd - travoprost - תמיסה לעין - travoprost 0.004 %w/v - travoprost - travoprost - for the reduction of elevated intra ocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other iop lowering medications or insufficiently responsive to another iop lowering medication.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - latanoprost - טיפות עיניים - latanoprost 50 mcg/ml - latanoprost - latanoprost - reduction of elevated intraocular pressure as a first line treatment in patients with open-angle glaucoma and ocular hypertension.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - latanoprost - טיפות עיניים - latanoprost 50 mcg/ml - latanoprost - latanoprost - reduction of elevated intraocular pressure as a first line treatment in patients with open-angle galucoma and ocular hypertension.

ישראל - עברית - Ministry of Health

bayer israel ltd - iloprost - תרכיז להכנת תמיסה לאינפוזיה - iloprost 0.1 mg/ml - iloprost - iloprost - peripheral arterial occlusive disease (stage 3 and 4 of fontaine's classification) in advanced arteriosclerosis, in whom surgery or angioplasty therapy is not possible.thromboangitis obliterans (buerger's disease) with critical limb ischemia in cases where revascularisation is not indicated and severe disabling raynaud's phenomenon .

ישראל - עברית - Ministry of Health

inovamed ltd - travoprost - תמיסה לעין - travoprost 40 mcg / 1 ml - travoprost

ישראל - עברית - Ministry of Health

inovamed ltd - travoprost - תמיסה לעין - travoprost 40 mcg / 1 ml - travoprost

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - travoprost - תמיסה לעין - travoprost 0.04 mg/ml - travoprost

ישראל - עברית - Ministry of Health

bayer israel ltd - iloprost - תמיסה לשאיפה - iloprost 0.01 mg/ml - iloprost